What are your thoughts on the NAD+ boosting study for lupus?

I recently came across a clinical trial for lupus that's using Nicotinamide Riboside to boost NAD+ levels and improve immunometabolism. The 'Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Lupus' study is still ongoing, but it's an interesting approach. What are your thoughts on this? Do you think this could be a game changer for lupus treatment?

Top Replies

It's definitely an exciting development in the field of lupus research! The idea of targeting immunometabolism is gaining traction in the scientific community, as it has the potential to address the underlying mechanisms of autoimmune diseases. However, we should keep in mind that this is just one study, and more research is needed to confirm its effectiveness and safety.

I'm always hopeful for new treatments, but I'm also cautious. I've been through so many trials and errors with different medications that it's hard to get my hopes up too high. That being said, I'm glad to see that researchers are exploring new pathways and approaches. I'm looking forward to seeing the results of this study!

It's important to remember that participating in clinical trials comes with its own set of challenges and uncertainties. While the potential benefits are promising, there may also be side effects or risks involved. It's crucial for patients to have a thorough discussion with their healthcare providers before deciding to participate in any clinical trial.

This is a relevant reply providing information about clinical trials for How do you feel about the approach used in the 'Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Lupus' study for addressing lupus challenges?

This is a relevant reply providing information about clinical trials for How do you feel about the approach used in the 'Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Lupus' study for addressing lupus challenges?